March 06, 2026

Framework Targets Hospital-Onset UTIs

The expert panel outlines surveillance, device management, and diagnostic stewardship strategies to address both catheter-associated and non–catheter-associated infections.

Conexiant

March 03, 2026

Penicillins Lead in SSI Prevention

Network meta-analysis compares antibiotic classes for colorectal surgery prophylaxis

Conexiant

March 03, 2026

Antibiotic Guideline Gaps Raise SSI Risk

Nonadherence to IDSA/SIS/SHEA perioperative antibiotic prophylaxis guidelines associated with significantly higher surgical site infection rates, finds nationwide analysis.

Conexiant

February 23, 2026

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

Conexiant

February 23, 2026

Rapunzel Syndrome Masks Weight Loss

Researchers identify an extensive trichobezoar in a child with progressive weight loss and feeding changes.

Conexiant

February 19, 2026

Income, BMI Linked to Colon Capsule Completion

Danish screening data identify clinical and socioeconomic factors that significantly influence whether colon capsule exams are completed.

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

June 02, 2025

Exercise After Chemotherapy Improves Colorectal Cancer Survival

A long-term clinical trial found that structured exercise after colon cancer treatment improved survival outcomes and reduced recurrence rates, offering evidence to support physical activity as part of survivorship care.

Conexiant

June 06, 2025

Lower-Dose Treatment Effective in Anal Cancer Trial, Study

In a recent clinical trial, researchers found that a reduced-dose chemoradiotherapy regimen for early-stage anal cancer may be comparable to standard treatment in achieving short-term tumor response, while causing fewer serious side effects.

Conexiant